Iterum Therapeutics' Series B - II Round

Iterum Therapeutics raised a round of funding on March 02, 2018.

Iterum Therapeutics is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combating the global crisis of multi-d…

Articles about Iterum Therapeutics' Series B - II Round: